Allay Pharmaceuticals, LLC

Form 483 issued May 15, 2020 · Miami, Florida

Inspection
May 5 – May 15, 2020
Observations
9
Pages
14
FEI number
3007007565

In short: On May 15, 2020, FDA issued a Form 483 with 9 observations to Allay Pharmaceuticals, LLC in Miami, Florida (FEI 3007007565) after an inspection that ran May 5 – May 15, 2020. The investigator was Jessica L. Pressley. Most observations concern quality system and laboratory controls.

At a glance

Quality system and laboratory controls account for 6 of 9 observations.

Quality system4
Laboratory controls2
Production1
Facilities & equipment1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Procedures describing the handling of written and oral complaints related to drug products are…

  3. 03

    EWPLOYEE(S) SIGNATURE Manufacturer There are no written procedures for production and process controls designed to assure…

  4. 04

    The written stability testing…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Allay Pharmaceuticals, LLC?

FDA listed 9 observations on this Form 483, mostly about quality system, laboratory controls and production. The opening words of each observation are shown on this page.

Who inspected Allay Pharmaceuticals, LLC?

Jessica L. Pressley is named on this Form 483, for the inspection of May 5 – May 15, 2020. Each investigator has a profile showing what they cite most.

When was Allay Pharmaceuticals, LLC inspected by FDA?

The inspection ran May 5 – May 15, 2020, and the Form 483 is dated May 15, 2020.

How do I get the full Form 483 for Allay Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free